March 07, 2023CorporateTerumo Prospective Registry Reinforces Safety, Efficacy and Efficiency of Radial Access in Visceral Interventions (R.A.V.I.) in Embolization ProceduresFindings show intra-vascular access via the radial artery can successfully be used as the primary strategy for the modern embolization practice
February 23, 2023CorporateTerumo Blood and Cell Technologies Presents First Quantum Flex Data for Multiple Size Bioreactors Showing Rapid T-Cell Expansion to Numbers Equivalent to a Therapeutic DosePresentation at CAR-TCR Summit Europe demonstrates scalability and reduced media usage enable lower cost to produce a dose of autologous T-cell therapy
Terumo Corporation ME Center 1002-1 Shimonagakubo, Nagaizumi-cho Suntou-gun, Shizuoka, 411-0934, Japan
Top
Top